Cancers prevented in Australia in 2010 through the consumption of aspirin

Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview

(2015) David C. Whiteman et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

Chemoprevention of colorectal cancer: systematic review and economic evaluation

(2014) K Cooper et al.   HEALTH TECHNOLOGY ASSESSMENT

Dose–Risk and Duration–Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies

(2013) Xiaohua Ye et al.   PLoS One

Aspirin and cancer risk: a quantitative review to 2011

(2012) C. Bosetti et al.   ANNALS OF ONCOLOGY

Effect of Aspirin on Vascular and Nonvascular Outcomes

(2012) Sreenivasa Rao Kondapally Seshasai   ARCHIVES OF INTERNAL MEDICINE

Aspirin and Cancer: Trials and Observational Studies

(2012) J. A. Baron   JNCI-Journal of the National Cancer Institute

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

The role of aspirin in cancer prevention

(2012) Michael J. Thun et al.   Nature Reviews Clinical Oncology

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Will an aspirin a day help keep fatal cancer away?

(2010) Eric J Jacobs   LANCET